Difference between revisions of "Center for Medicine in the Public Interest"
Line 1: | Line 1: | ||
+ | |||
+ | ==CMPI Board of Directors== | ||
+ | |||
+ | The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future. | ||
+ | |||
+ | Bruce Booth | ||
+ | |||
+ | |||
+ | Principal, | ||
+ | Atlas Venture | ||
+ | |||
+ | Bruce Brandfon | ||
+ | |||
+ | |||
+ | Publisher, | ||
+ | Scientific American | ||
+ | |||
+ | Fred Goodwin, M.D. | ||
+ | |||
+ | |||
+ | Professor of Psychiatry, | ||
+ | The George Washington University Medical Center. | ||
+ | |||
+ | Dennis Johnson | ||
+ | |||
+ | |||
+ | Vice President, | ||
+ | Policy and External Affairs at The Children’s Health Fund | ||
+ | |||
+ | Suzanne Pattee, J.D. | ||
+ | |||
+ | |||
+ | Vice president, | ||
+ | Public Policy and Patient Affairs for the Cystic Fibrosis | ||
+ | |||
+ | Steven Sammut | ||
+ | |||
+ | |||
+ | Lecturer, | ||
+ | Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania | ||
+ | |||
+ | Mark Thornton, M.D., Ph.D. | ||
+ | |||
+ | |||
+ | Chairman and President, | ||
+ | Sarcoma Foundation of America | ||
+ | |||
+ | Michael Weber, M.D. | ||
+ | |||
+ | |||
+ | Associate Dean and Professor of Medicine | ||
+ | SUNY Downstate College of Medicine | ||
+ | Brooklyn, New York | ||
+ | |||
+ | Raymond Woosley, M.D., Ph.D. | ||
+ | |||
+ | |||
+ | President and CEO, | ||
+ | C-Path Institute. | ||
==CMPI Advisory Board== | ==CMPI Advisory Board== |
Revision as of 10:59, 3 April 2007
CMPI Board of Directors
The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
Bruce Booth
Principal,
Atlas Venture
Bruce Brandfon
Publisher,
Scientific American
Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.
Dennis Johnson
Vice President,
Policy and External Affairs at The Children’s Health Fund
Suzanne Pattee, J.D.
Vice president,
Public Policy and Patient Affairs for the Cystic Fibrosis
Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America
Michael Weber, M.D.
Associate Dean and Professor of Medicine
SUNY Downstate College of Medicine
Brooklyn, New York
Raymond Woosley, M.D., Ph.D.
President and CEO,
C-Path Institute.
CMPI Advisory Board
Joesph L. Bast President and CEO The Heartland Institute Chicago, IL
John E. Calfee
Senior Fellow
American Enterprise Institute
Washington, D.C.
Joseph A. DiMasi, Ph.D.
Director of Economic Analysis
Tufts Center for the Study of Drug Development
Tufts University, Boston, MA
Helen Disney
Director
Stockholm Network
London, England
John Kamp
Executive Director
Coalition for Healthcare Communication
Sam Kazman
General Counsel
Competitive Enterprise Institute
Dr. Merrill Mathews, Jr.
Resident Scholar
Institute for Policy Innovation
Director
Council for Affordable Health Insurance
David McIntosh
Attorney
Mayer, Brown, Rowe & Maw LLP
Washington, DC.
Julian Morris
Director
International Policy Network (London)
Tomas J. Philipson
Professor
The Harris School
Chicago, IL
Stephen Pollard
Senior Fellow at the Centre for the New Europe
Brussels, Belgium
William Roper
CEO
University of North Carolina Health Care System
Ellen V. Sigal, Ph.D.
Founder and Chairperson
Friends of Cancer Research
Sam Silverstein, M.D.
John C. Dalton Professor of Physiology
and Cellular Biophysic
Professor of Medicine
Columbia University
Philip Stieg, MD
Professor and Chairman
Department of Neurological Surgery
Weill Medical College
Neurosurgeon-in-Chief
New York-Presbyterian Hospital
Daniel E. Troy
Former Chief Counsel of the FDA
Partner in the Washington, New York Offices of
Sidley Austin Brown and Wood
Grace Marie Turner
President
The Galen Institute
Ben Zycher
Senior Fellow in Economics
Pacific Research Institute
Adjunct scholar
Cato Institute, Claremont Institute